1. Shahbazian H, Rezaii I (2013) Diabetic kidney disease; review of the current knowledge. J Ren Inj Prev 2(2):73–80
2. Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T (2016) Diabetic kidney disease: worldwide difference of prevalence and risk factors. J Nephropharmacol 5(1):49–56
3. Taha H, Mahmoud HH, Soliman AS, Taha MM, Mohammed RA (2019) The Association between Highly Sensitive C-Reactive Protein and Interleukin-18 with Nephropathy in a Sample of Type 1 Diabetic Egyptian Patients. Med J Cairo Univ 87(4):2393–2402
4. Qin J, Peng Z, Yuan Q, Li Q et al (2019) AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways. Sci Rep 9(1):4407
5. Donate-Correa J, Ferri CM, Sánchez-Quintana F et al (2021) Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications. Front Med (Lausanne) 7:628289